The research findings on immune support:
PLT shared the results of the research, in which healthy subjects who reported air pollution sensitivity took either 200 mg/day of AlvioLife or a matching placebo. Subjects taking AlvioLife experienced statistically significant improvements from baseline and compared to placebo for:- lung function
- lung capacity
- aerobic exercise capacity
“It’s easy to forget how many aspects of our lives are dependent on respiratory health – from overall health to emotional well-being to physical performance," said Seth Flowerman, President & CEO of PLT Health Solutions, in a press release. "And factors like environmental pollution can challenge optimal respiratory health. AlvioLife can function as a standalone ingredient to support respiratory function for people who have respiratory sensitivities or live in higher pollution areas, as well as a component in immune health formulations – since the issue of respiratory health is so vital to the immune health equation. For companies looking to differentiate and enhance their immune health formulations, AlvioLife offers some unique benefits."
Combatting inflammation
AlvioLife is a patented composition of Boswellia serrata resin extract standardized to 30% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) and Bengal quince fruit extracts (Aegle marmelos), PLT shared. Some highlights of the herbal combination, as outlined in the release:- It works via mechanisms that help balance the inflammatory response.
- It has been shown to possess stronger 5-lipoxygenase (5-LOX) inhibition activity than either of its constituent extracts alone.
- The 5-lipoxygenase enzyme has been shown in the literature to have significant influence on the onset and progression of airway inflammation.
Additional research findings
In a second double-blind trial (currently in pre-publication), healthy subjects with self-reported sensitivity to pollution took 200 mg/d of AlvioLife or a matching placebo for six weeks. AlvioLife was shown to improve:- improve lung function (FEV1) by up to 16%
- improvelung capacity (FVC) by up to 30%
- improve aerobic exercise capacity by up to 7% (6-minute Walk test)
- reduce upper respiratory tract symptoms (WURSS-21) by up to ~40%
- improve perceived immune status (ISQ) in as early as three weeks
- improve psychological well-being (PGWBI) by up to 18%
- improve the percentage of CD4+ T Helper Cells.